Irritable bowel syndrome: modern ideas about pathology and the possibility of its correction

Q4 Medicine Meditsinskiy Sovet Pub Date : 2023-11-04 DOI:10.21518/ms2023-380
S. Yu. Serebrova, D. O. Kurguzova, L. M. Krasnykh, G. F. Vasilenko, E. Yu. Demchenkova, N. N. Eremenko, E. N. Kareva, A. B. Prokofiev
{"title":"Irritable bowel syndrome: modern ideas about pathology and the possibility of its correction","authors":"S. Yu. Serebrova, D. O. Kurguzova, L. M. Krasnykh, G. F. Vasilenko, E. Yu. Demchenkova, N. N. Eremenko, E. N. Kareva, A. B. Prokofiev","doi":"10.21518/ms2023-380","DOIUrl":null,"url":null,"abstract":"Among the defecating disorders with constipation or diarrhea, there is a group of major intestinal disorders defined by the Rome IV Diagnostic Criteria (2016): irritable bowel syndrome, functional constipation, functional diarrhea. The presence of several updates of the Rome criteria is due to the current lack of objective signs of the listed disorders while many options for describing subjective sensation by patients from different countries. It calls for their terminological multilingual standardization. Both constipation and diarrhea can be caused by a variety of exogenous and endogenous factors and have different pathogenetic mechanisms, but they cannot be identified properly using modern clinical and laboratory methods for functional intestinal disorders. However, the high prevalence of these syndromes, characterized by the presence of complaints that reduce patients’ quality of life, necessitates their correction. The drug choice for defecation disorders and abdominal pain is often limited by contradictions from international clinical guidelines and national regulations.Therefore, the Recommendations of the Russian Gastroenterological Association for the treatment of functional intestinal diseases contain many instructions on general therapeutic and dietary measures. The pain syndrome treatment is based on the spasmolytics. Among the laxatives that have long been used in the treatment of chronic constipation, sodium picosulfate has long been successfully used. This drug has high efficacy and safety profiles; the instructions for its medical use allow to prescribe it in patients suffered from irritable bowel syndrome with constipation. The use of sodium picosulfate for IBS is regulated by many clinical recommendations. However, this drug may be ineffective against abdominal pain. It is incorrect to assign the mission of pain relief to a laxative because of multifactorial pathogenesis of IBS pain with constipation or diarrhea and uncertainty of methods for its pharmacological control.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Meditsinskiy Sovet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21518/ms2023-380","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Among the defecating disorders with constipation or diarrhea, there is a group of major intestinal disorders defined by the Rome IV Diagnostic Criteria (2016): irritable bowel syndrome, functional constipation, functional diarrhea. The presence of several updates of the Rome criteria is due to the current lack of objective signs of the listed disorders while many options for describing subjective sensation by patients from different countries. It calls for their terminological multilingual standardization. Both constipation and diarrhea can be caused by a variety of exogenous and endogenous factors and have different pathogenetic mechanisms, but they cannot be identified properly using modern clinical and laboratory methods for functional intestinal disorders. However, the high prevalence of these syndromes, characterized by the presence of complaints that reduce patients’ quality of life, necessitates their correction. The drug choice for defecation disorders and abdominal pain is often limited by contradictions from international clinical guidelines and national regulations.Therefore, the Recommendations of the Russian Gastroenterological Association for the treatment of functional intestinal diseases contain many instructions on general therapeutic and dietary measures. The pain syndrome treatment is based on the spasmolytics. Among the laxatives that have long been used in the treatment of chronic constipation, sodium picosulfate has long been successfully used. This drug has high efficacy and safety profiles; the instructions for its medical use allow to prescribe it in patients suffered from irritable bowel syndrome with constipation. The use of sodium picosulfate for IBS is regulated by many clinical recommendations. However, this drug may be ineffective against abdominal pain. It is incorrect to assign the mission of pain relief to a laxative because of multifactorial pathogenesis of IBS pain with constipation or diarrhea and uncertainty of methods for its pharmacological control.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肠易激综合征:现代病理观念及其矫正的可能性
在便秘或腹泻的排便障碍中,有一组由罗马IV诊断标准(2016)定义的主要肠道疾病:肠易激综合征、功能性便秘、功能性腹泻。罗马标准的几次更新是由于目前缺乏所列疾病的客观迹象,而来自不同国家的患者有许多描述主观感觉的选择。它要求他们的术语多语言标准化。便秘和腹泻均可由多种外源性和内源性因素引起,并具有不同的发病机制,但使用现代功能性肠道疾病的临床和实验室方法无法正确识别。然而,这些综合征的高患病率,其特点是存在降低患者生活质量的抱怨,需要对其进行纠正。排便障碍和腹痛的药物选择往往受到国际临床指南和国家法规的矛盾的限制。因此,俄罗斯胃肠病学协会关于功能性肠道疾病治疗的建议包含许多关于一般治疗和饮食措施的说明。疼痛综合征的治疗是基于解痉。在长期用于治疗慢性便秘的泻药中,picosulfate钠一直被成功使用。该药具有高疗效和安全性;其医疗用途的说明允许在患有肠易激综合征伴便秘的患者中开处方。pico硫酸钠治疗肠易激综合征的使用受到许多临床建议的管制。然而,这种药对腹痛可能无效。由于IBS疼痛伴便秘或腹泻的多因素发病机制以及其药理控制方法的不确定性,将缓解疼痛的任务分配给泻药是不正确的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Meditsinskiy Sovet
Meditsinskiy Sovet Medicine-Medicine (all)
CiteScore
0.70
自引率
0.00%
发文量
418
审稿时长
6 weeks
期刊最新文献
Direct comparative study of the effectiveness of mepolizumab and dupilumab in patients with severe non-allergic eosinophilic asthma Possibilities of modern pharmacotherapy in patients with dysfunction of the sphincter of Oddi Microscopic colitis of incomplete collagen type in combination with lactase deficiency Approaches to the management of surgical patients with antibiotic-associated mild diarrhea Irritable bowel syndrome: modern ideas about pathology and the possibility of its correction
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1